BACKGROUND: The proinflammatory cytokine interleukin-18 (IL-18) is associated with major disabling conditions, although whether as byproduct or driver is unclear. The role of common variation in the IL-18 gene on serum concentrations and functioning in old age is unknown. METHODS: We used 1671 participants aged 65-80 years from two studies: the InCHIANTI study and wave 6 of the Iowa-Established Populations for Epidemiological Study of the Elderly (EPESE). We tested three common polymorphisms against IL-18 concentration and measures of functioning. RESULTS: In the InCHIANTI study, a 1 standard deviation increase in serum IL-18 concentrations was associated with an increased chance of being in the 20% of slowest walkers (odds ratio 1.45; 95% confidence interval, 1.17-1.80; p =.0007) and 20% of those with poorest function based on the Short Physical Performance Battery Score (odds ratio 1.52; 95% confidence interval, 1.22-1.89; p =.00016) in age sex adjusted logistic regression models. There was no association with Activities of Daily Living (p =.26) or Mini-Mental State Examination score (p =.66). The C allele of the IL-18 polymorphism rs5744256 reduced serum concentrations of IL-18 by 39 pmol/mL per allele (p =.00001). The rs5744256 single nucleotide polymorphism was also associated with shorter walk times in InCHIANTI (n = 662, p =.016) and Iowa-EPESE (n = 995, p =.026). In pooled ranked models rs5744256 was also associated with higher SPPB scores (n = 1671, p =.019). Instead of adjusting for confounders in the IL-18 walk time association, we used rs5744256 in a Mendelian randomization analysis: The association remained in instrumental variable models (p =.021). CONCLUSION: IL-18 concentrations are associated with physical function in 65- to 80-year-olds. A polymorphism in the IL-18 gene alters IL-18 concentrations and is associated with an improvement in walk speed. IL-18 may play an active role in age-related functional impairment, but these findings need independent replication.
BACKGROUND: The proinflammatory cytokine interleukin-18 (IL-18) is associated with major disabling conditions, although whether as byproduct or driver is unclear. The role of common variation in the IL-18 gene on serum concentrations and functioning in old age is unknown. METHODS: We used 1671 participants aged 65-80 years from two studies: the InCHIANTI study and wave 6 of the Iowa-Established Populations for Epidemiological Study of the Elderly (EPESE). We tested three common polymorphisms against IL-18 concentration and measures of functioning. RESULTS: In the InCHIANTI study, a 1 standard deviation increase in serum IL-18 concentrations was associated with an increased chance of being in the 20% of slowest walkers (odds ratio 1.45; 95% confidence interval, 1.17-1.80; p =.0007) and 20% of those with poorest function based on the Short Physical Performance Battery Score (odds ratio 1.52; 95% confidence interval, 1.22-1.89; p =.00016) in age sex adjusted logistic regression models. There was no association with Activities of Daily Living (p =.26) or Mini-Mental State Examination score (p =.66). The C allele of the IL-18 polymorphism rs5744256 reduced serum concentrations of IL-18 by 39 pmol/mL per allele (p =.00001). The rs5744256 single nucleotide polymorphism was also associated with shorter walk times in InCHIANTI (n = 662, p =.016) and Iowa-EPESE (n = 995, p =.026). In pooled ranked models rs5744256 was also associated with higher SPPB scores (n = 1671, p =.019). Instead of adjusting for confounders in the IL-18 walk time association, we used rs5744256 in a Mendelian randomization analysis: The association remained in instrumental variable models (p =.021). CONCLUSION:IL-18 concentrations are associated with physical function in 65- to 80-year-olds. A polymorphism in the IL-18 gene alters IL-18 concentrations and is associated with an improvement in walk speed. IL-18 may play an active role in age-related functional impairment, but these findings need independent replication.
Authors: Sebastiano Gangemi; Giorgio Basile; Rosaria Alba Merendino; Paola Lucia Minciullo; Daniela Novick; Menachem Rubinstein; Charles A Dinarello; Claudia Lo Balbo; Claudio Franceschi; Stefania Basili; Etrusca D' Urbano; Giovanni Daví; Vittorio Nicita-Mauro; Mario Romano Journal: Exp Gerontol Date: 2003-06 Impact factor: 4.032
Authors: Stefan Blankenberg; Gérald Luc; Pierre Ducimetière; Dominique Arveiler; Jean Ferrières; Philippe Amouyel; Alun Evans; François Cambien; Laurence Tiret Journal: Circulation Date: 2003-10-27 Impact factor: 29.690
Authors: Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang Journal: Alzheimers Dement Date: 2014-07-09 Impact factor: 21.566
Authors: Meian He; Marilyn C Cornelis; Peter Kraft; Rob M van Dam; Qi Sun; Cathy C Laurie; Daniel B Mirel; Daniel I Chasman; Paul M Ridker; David J Hunter; Frank B Hu; Lu Qi Journal: Arterioscler Thromb Vasc Biol Date: 2010-02-11 Impact factor: 8.311
Authors: S Rafiq; D Melzer; M N Weedon; H Lango; R Saxena; L J Scott; C N A Palmer; A D Morris; M I McCarthy; L Ferrucci; A T Hattersley; E Zeggini; T M Frayling Journal: Diabetologia Date: 2008-10-14 Impact factor: 10.122
Authors: Kate Thomas; Sajjad Rafiq; Timothy M Frayling; Shah Ebrahim; Meena Kumari; John Gallacher; Luigi Ferrucci; Stefania Bandinelli; Robert B Wallace; David Melzer; Richard M Martin; Yoav Ben-Shlomo Journal: J Gerontol A Biol Sci Med Sci Date: 2009-07-24 Impact factor: 6.053
Authors: A M Matteini; J Li; E M Lange; T Tanaka; L A Lange; R P Tracy; Y Wang; M L Biggs; D E Arking; M D Fallin; A Chakravarti; B M Psaty; S Bandinelli; L Ferrucci; A P Reiner; J D Walston Journal: Cytokine Date: 2013-10-29 Impact factor: 3.861